Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00572624 · ClinicalTrials.gov registry record · NA

Effect of Weight Loss on Myocardial Metabolism and Cardiac Relaxation in Obese Adults

A NA study, sponsored by Washington University School of Medicine.

Completed
Registry status
NA
Development phase
51
Enrollment target

NCT00572624: Completed NA study, sponsored by Washington University School of Medicine.

NCT00572624 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 51 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00572624, a NA study, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
NA
Development phase
51 participants
Enrollment target

Study Summary

Obesity adversely affects myocardial (muscular heart tissue) metabolism, efficiency, and diastolic function. The objective of this study was to determine if weight loss could improve obesity-related myocardial metabolism and efficiency and if these improvements were directly related to improved diastolic function.

Primary Outcome

The evening before an imaging study, all participants were given a meal containing 12 kcal/kg adjusted body weight (=ideal body weight + ((actual body weight-ideal body weight) x 0.25)). Participants fasted until their imaging studies were completed. Myocardial oxygen consumption (MVO2) was measured using positron emission tomography (PET) following injection of 1-\^11C-acetate. Total MVO2 was calculated by multiplying the MVO2 measure by left ventricular weight.

Interventions

  • BEHAVIORAL Diet
  • PROCEDURE Gastric bypass surgery

Trial Details

FieldValue
Enrollment Target 51 participants
Start Date 2003-06
Est. Completion 2014-06
Phase NA

What the finished NCT00572624 record still lists

NCT00572624 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 51 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 2 interventions - of which Diet is the first listed.

NCT00572624 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00572624 about?

NCT00572624 is a clinical study titled "Effect of Weight Loss on Myocardial Metabolism and Cardiac Relaxation in Obese Adults". Obesity adversely affects myocardial (muscular heart tissue) metabolism, efficiency, and diastolic function. The objective of this study was to determine if weight loss could improve obesity-related myocardial metabolism and efficiency and if these improvements were directly related to improved dias...

What is the current status of trial NCT00572624?

This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2003-06. Estimated completion is 2014-06.

What interventions are being tested in trial NCT00572624?

The interventions under investigation include: Diet (BEHAVIORAL), Gastric bypass surgery (PROCEDURE).

Who is sponsoring clinical trial NCT00572624?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00572624's enrollment target sits among peer trials

51 1279th of 2000 higher than 722 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02701153 · 51 participants · NA

    Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort

  • NCT03663790 · 51 participants · NA

    Effects of Gait Retraining on Lower Extremity Biomechanics

  • NCT03874052 · 51 participants · Phase 1

    Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

  • NCT04704661 · 51 participants · Phase 1

    Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00572624, the US trial registry maintained by the National Library of Medicine. NCT00572624 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.